article thumbnail

Europe’s pharmaceutical packaging market to value over $35bn by 2028

European Pharmaceutical Review

Europe’s pharmaceutical packaging and labelling market is projected to reach $35.78 billion in 2028, according to a report by Arizton. billion in 2022, the pharmaceutical packaging and labelling market in Europe is expected to expand at a compound annual growth rate (CAGR) of 4.78 percent up to 2028. percent in 2022.

Packaging 118
article thumbnail

Körber absorbs Wilhelm Bähren to expand pharma packaging toolbox

Outsourcing Pharma

Discover how a strategic acquisition in pharma packaging is set to drive growth as the market aims to double by 2028

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

USP General Chapter —Glass revised

European Pharmaceutical Review

In response to supply chain challenges, including shortages of critical glass vials for products like COVID-19 vaccines and parenteral drugs, the Packaging and Distribution Expert Committee (PD EC) has made a significant revision of United States Pharmacopeia (USP) General Chapter <660>—Glass.

Packaging 105
article thumbnail

European regulators prepare for AI in pharma

European Pharmaceutical Review

The workplan, which runs until 2028, will help the European medicines regulatory network (EMRN) embrace the opportunities of AI for personal productivity, automating processes and systems, increasing insights into data and supporting more robust decision-making to benefit public and animal health.

Packaging 105
article thumbnail

Novo Nordisk to expand French production facilities

European Pharmaceutical Review

These activities are expected to be completed incrementally between 2026 to 2028, the company stated. Novo Nordisk declared that it will help to boost its global capacity, “from manufacturing of active pharmaceutical ingredients (API) through to packaging.” Construction has already begun.

article thumbnail

EU tax compliance proposals to streamline business investment

European Pharmaceutical Review

Transfer pricing proposal As part of the EC’s package of initiatives to reduce tax compliance costs, there is a proposal specifically aimed at harmonising transfer pricing rules in the EU. SMEs are also set to benefit, although the rules will be discretionary.

article thumbnail

STAT+: Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant investments and more

STAT

This calls for celebration with a cup of stimulation, and we are opening a new package of pecan pie for the occasion. In a press release issued ahead of an investor meeting today, the company also said it plans to break even by 2028, when it expects it will reach annual sales of $6 billion. Sound familiar?